Halme, M <br/><br/>
Phase II study of weekly gemcitabine in advanced non-small cell lung cancer.  [electronic resource] 

 -  Respiratory medicine  Aug 1997 
 - 423-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0954-6111 
<br/><br/><label>Standard No.: </label>10.1016/s0954-6111(97)90257-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Deoxycytidine--adverse effects<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Survival Rate<br/>Treatment Outcome<br/>Gemcitabine